5 news items
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
MYGN
QGEN
30 May 24
Patrick Burke, Executive Vice President of Strategy and Innovation, Myriad Genetics. "By extending the global reach and ease of access to Myriad's gold
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine
QGEN
29 May 24
innovative NGS technologies for genomics, transcriptomics, epigenomics, and metagenomics applications. QIAGEN's QIAseq kits
QIAGEN Expands Tuberculosis Portfolio With New NGS Panel To Support Real-Time Surveillance And Combat Antimicrobial Resistance
QGEN
24 Apr 24
fluid. This innovation significantly reduces the time to result and enables real-time epidemiology of TB outbreaks, addressing a critical need
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
QGEN
24 Apr 24
) directly from samples such as sputum or cerebrospinal fluid. This innovation significantly reduces the time to result and enables real-time epidemiology
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
QGEN
3 Apr 24
in this field. "We are excited to share our latest innovation in digital PCR, NGS, and non-invasive sample collection and DNA
- Prev
- 1
- Next